Max Robotics — Global Service Robot Directory + US Certification

About

Peng Liu is a researcher whose work spans two distinct but impactful biomedical domains: cancer immunology and minimally invasive spinal surgery. In oncology, Liu has made significant contributions to the understanding of immunogenic cell death and therapeutic strategies that harness the immune system to fight cancer. His highly cited 2016 study on LTX-315 — accumulating 129 citations — demonstrated how this cationic amphilytic peptide selectively disrupts mitochondrial membranes, inducing caspase-independent necrosis and stimulating robust T lymphocyte-mediated antitumor immunity. Building on immuno-oncology themes, his 2021 investigation into IGF1 receptor inhibition revealed how combining targeted inhibitors with autophagy-enhancing mechanisms can amplify anticancer drug efficacy through both immune-dependent and cellular pathways, garnering 77 citations. More recently, Liu has applied his rigorous comparative methodology to orthopedic surgery, examining robot-assisted percutaneous pedicle screw fixation for thoracolumbar burst fractures. Across these fields, Liu demonstrates a consistent commitment to translational research — bridging mechanistic discoveries with clinically meaningful outcomes — making his work particularly valuable for researchers and clinicians working at the intersection of cancer biology, immunotherapy, and surgical innovation.